Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450].
作者信息
Haratake Naoki, Ozawa Hiroki, Morimoto Yoshihiro, Yamashita Nami, Daimon Tatsuaki, Bhattacharya Atrayee, Wang Keyi, Nakashoji Ayako, Isozaki Hideko, Shimokawa Mototsugu, Kikutake Chie, Suyama Mikita, Hashinokuchi Asato, Takada Kazuki, Takenaka Tomoyoshi, Yoshizumi Tomoharu, Mitsudomi Tetsuya, Hata Aaron N, Kufe Donald
机构信息
Department of Medical Oncology, Dana-Farber Cancer Institute Harvard Medical School, Boston, Massachusetts.
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
出版信息
J Thorac Oncol. 2025 Mar;20(3):399. doi: 10.1016/j.jtho.2024.12.004. Epub 2024 Dec 18.
PMID:39692639
Abstract
摘要
Zotero 插件